Acitretin chemoprevention in patients with nonmelanoma skin cancer with chronic haematopoietic disease: findings from three independent databases.

Sia T, Li S, Zhong X, Park C, Abou-Taleb F, Twigg AR, Che Y, Chang ALS.

Open source

DOI
10.1093/bjd/ljaf221
Published
2025-09-01
Container
Br J Dermatol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/bjd/ljaf221,
  title = {Acitretin chemoprevention in patients with nonmelanoma skin cancer with chronic haematopoietic disease: findings from three independent databases.},
  author = {Sia T and  Li S and  Zhong X and  Park C and  Abou-Taleb F and  Twigg AR and  Che Y and  Chang ALS.},
  year = {2025},
  journal = {Br J Dermatol},
  doi = {10.1093/bjd/ljaf221},
  url = {https://doi.org/10.1093/bjd/ljaf221}
}

RIS

TY  - JOUR
TI  - Acitretin chemoprevention in patients with nonmelanoma skin cancer with chronic haematopoietic disease: findings from three independent databases.
AU  - Sia T
AU  -  Li S
AU  -  Zhong X
AU  -  Park C
AU  -  Abou-Taleb F
AU  -  Twigg AR
AU  -  Che Y
AU  -  Chang ALS.
PY  - 2025
JO  - Br J Dermatol
DO  - 10.1093/bjd/ljaf221
UR  - https://doi.org/10.1093/bjd/ljaf221
ER  - 

APA

T, S., S, L., X, Z., C, P., F, A., AR, T., Y, C., & ALS., C. (2025). Acitretin chemoprevention in patients with nonmelanoma skin cancer with chronic haematopoietic disease: findings from three independent databases.. Br J Dermatol. https://doi.org/10.1093/bjd/ljaf221

Source records